5 Results for "

cancer-selective

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "cancer-selective" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-136310
CAS No.: 2055405-95-1
Purity:  98.92%
Target:  

PI5P4K

Research Areas:  

Cancer

PIP4K-IN-a131 is PIP4K lipid kinases inhibitor, with IC50s of 1.9 μM and 0.6 μM for purified PIP4K2A and PIP4Ks, respectively. PIP4K-IN-a131 exhibits cancer-selective lethality via dual blockade of the lipid kinase PIP4Ks and mitotic pathways .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100538
CAS No.: 1809784-29-9
Purity:  99.56%
Target:  

DNA/RNA Synthesis JAK

Research Areas:  

Cancer

DTP3 TFA is a potent and selective GADD45β/MKK7 inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100538A
CAS No.: 2759216-46-9
Purity:  98.00%
Target:  

DNA/RNA Synthesis JNK

Research Areas:  

Cancer

DTP3 TFA is a potent and selective GADD45β/MKK7 (growth arrest and DNA-damage-inducible β/mitogen-activated protein kinase kinase 7) inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway .
loading...
    loading...
Cat. No.: HY-15313B
CAS No.: 2070014-96-7
Purity:  ≥98.0%
Target:  

Histone Demethylase

Research Areas:  

Metabolic Disease Cancer

CBB1007 hydrochloride is a reversible and selective LSD1 inhibitor with an IC50 of 5.27 µM for human LSD1. CBB1007 hydrochloride significantly blocks the demethylase activity of LSD1 on H3K4Me2 and H3K4Me. CBB1007 hydrochloride shows selectivity for LSD1 over LSD2 or JARID1A, and induces differentiation-related genes in pluripotent cells. CBB1007 hydrochloride is studied in  non-pluripotent cancer research, targeting teratocarcinoma, embryonic carcinoma, and seminoma .
loading...
    loading...
Cat. No.: HY-100538R
CAS No.: 1809784-29-9
Research Areas:  

Cancer

DTP3 (Standard) is the analytical standard of DTP3 (HY-100538). This product is intended for research and analytical applications. DTP3 TFA is a potent and selective GADD45β/MKK7 inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway .
loading...
    loading...